Govt forms 5-member committee to review pharma marketing practices – The central government has a five-member committee, aimed at considering a “legally enforceable” mechanism for regulating the marketing practices of pharmaceutical firms. V K Paul, member (health) of NITI Aayog has been elected as the head of the committee.
- The committee will submit its report in 90 days.
- It will help in examining the provisions government departments have to regulate pharmaceutical marketing practices and align interventions for implementation by the healthcare industry.
The members of the committee
- V K Paul, member (health) of NITI Aayog – Chairman of the committee
- S Aparna, secretary in department of pharmaceuticals (DoP);
- Rajesh Bhushan, secretary in the ministry of health and family welfare (MoHFW);
- Nitin Gupta, chairman of the Central Board of Direct Taxes (CBDT);
- a joint secretary (policy) from the department of personnel (DoP)
Universal Code of Pharmaceutical Marketing Practices (UCPMP)
- The DoP’s Universal Code of Pharmaceutical Marketing Practices (UCPMP) for pharmaceutical firms came into effect in January 2015.
- As per the UCPMP, Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, which comes under the Medical Council Act, 1956 details the relationship between healthcare professionals and pharmaceutical companies.
******** End ********
★★★★ You Can Also Read ★★★★
|Computer Awareness Quiz Questions Set (Banking)|
|Read Daily Current Affairs Topic Wise|
|Daily Current Affairs Quiz (Current GK Test)|
|Static Gk Quiz Questions and Answers|